世界のB型肝炎ワクチン市場:成長動向・競争分析2020-2026

【英語タイトル】Global Hepatitis B Vaccines Industry Research Report, Growth Trends and Competitive Analysis 2020-2026

QYResearchが出版した調査資料(QYR20AP00992)・商品コード:QYR20AP00992
・発行会社(調査会社):QYResearch
・発行日:2020年3月16日(※2024年版があります。お問い合わせください)
・ページ数:113
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥725,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥1,087,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,450,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
当リサーチレポートでは、B型肝炎ワクチンの世界市場規模が2019年xx百万ドルから2026年xx百万ドルまで年平均xx%成長すると予測しています。当レポートは、B型肝炎ワクチンのグローバル市場動向、メーカー別競争状況、種類別市場規模(モノワクチン、混合ワクチン)、用途別市場規模(adr、adw、ayr、ayw)、北米市場、アジア市場、中南米市場、中東・アフリカ市場分析、関連企業情報、サプライチェーン、販売チャネル分析、地域別市場規模予測データなどを掲載しています。

・レポート概要
・グローバル市場動向
・メーカー別競争状況
・B型肝炎ワクチンの種類別市場2015-2026:モノワクチン、混合ワクチン
・B型肝炎ワクチンの用途別市場2015-2026:adr、adw、ayr、ayw
・B型肝炎ワクチンの北米市場分析
・B型肝炎ワクチンのアジア市場分析
・B型肝炎ワクチンの中南米市場分析
・B型肝炎ワクチンの中東・アフリカ市場分析
・関連企業情報:GlaxoSmithKline、Merck、Sanofi Pasteur、Dynavax Technologies、Janssen Pharmaceuticals、LG Life Sciences、KM Biologics、Shenzhen Kangtai Biological Products
・サプライチェーン及び販売チャネル分析
・地域別市場規模予測2021-2026:北米、ヨーロッパ、アジア、中南米、中東・アフリカ
・結論
【レポートの概要】

In 2019, the global Hepatitis B Vaccines market size was US$ 1597.1 million and is forecast to US$ 1942.9 million in 2026, growing at a CAGR of 2.8% from 2020. In this study, 2019 has been considered as the base year and 2020 to 2026 as the forecast period to estimate the market size for Hepatitis B Vaccines.The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Hepatitis B Vaccines market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Hepatitis B Vaccines market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Hepatitis B Vaccines market. Readers of the report can become informed about current and future trends of the global Hepatitis B Vaccines market and how they will impact market growth during the forecast period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise and country-wise Hepatitis B Vaccines markets such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E etc.
For the period 2015-2026, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Hepatitis B Vaccines market. For the period 2015-2020, it provides sales (consumption) analysis and forecast of different regional markets by Application as well as by Type in terms of volume.
Market Segmentation by Type and by Application
The report includes a detailed analysis of leading and by Type and by Application segments of the global Hepatitis B Vaccines market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue, sales analysis and forecast of the global Hepatitis B Vaccines market by Type and by Application segment for the period 2015-2026.

Market Segment by Type, the Hepatitis B Vaccines market is segmented into
Mono Vaccines
Combination Vaccines

Market Segment by Application, the Hepatitis B Vaccines market is segmented into
adr
adw
ayr
ayw

This report includes the following manufacturers; we can also add the other companies as you want.
GlaxoSmithKline
Merck
Sanofi Pasteur
Dynavax Technologies
Janssen Pharmaceuticals
LG Life Sciences
KM Biologics
Shenzhen Kangtai Biological Products

The study objectives are:
To analyze and research the global Hepatitis B Vaccines status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Hepatitis B Vaccines manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Hepatitis B Vaccines are as follows:
History Year: 2015-2020
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Top Hepatitis B Vaccines Manufacturers Covered: Ranking by Revenue
1.3 Market Segment by Type
1.3.1 Global Hepatitis B Vaccines Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)
1.3.2 Mono Vaccines
1.3.3 Combination Vaccines
1.4 Market Segment by Application
1.4.1 Global Hepatitis B Vaccines Consumption by Application: 2015 VS 2020 VS 2026
1.4.2 adr
1.4.3 adw
1.4.4 ayr
1.4.5 ayw
1.5 Study Objectives
1.6 Years Considered
2 Global Market Perspective
2.1 Global Hepatitis B Vaccines Revenue (2015-2026)
2.1.1 Global Hepatitis B Vaccines Revenue (2015-2026)
2.1.2 Global Hepatitis B Vaccines Sales (2015-2026)
2.2 Hepatitis B Vaccines Market Size across Key Geographies Worldwide: 2015 VS 2020 VS 2026
2.2.1 Global Hepatitis B Vaccines Sales by Regions (2015-2020)
2.2.2 Global Hepatitis B Vaccines Revenue by Regions (2015-2020)
2.3 Global Top Hepatitis B Vaccines Regions (Countries) Ranking by Market Size
2.4 Hepatitis B Vaccines Industry Trends
2.4.1 Hepatitis B Vaccines Market Top Trends
2.4.2 Market Drivers
2.4.3 Hepatitis B Vaccines Market Challenges
2.4.4 Porter’s Five Forces Analysis
2.4.5 Primary Interviews with Key Hepatitis B Vaccines Players: Views for Future

3 Competitive Landscape by Manufacturers
3.1 Global Top Hepatitis B Vaccines Manufacturers by Sales (2015-2020)
3.1.1 Global Hepatitis B Vaccines Sales by Manufacturers (2015-2020)
3.1.2 Global Hepatitis B Vaccines Sales Market Share by Manufacturers (2015-2020)
3.1.3 Global 5 and 10 Largest Manufacturers by Hepatitis B Vaccines Sales in 2019
3.2 Global Top Manufacturers Hepatitis B Vaccines by Revenue
3.2.1 Global Hepatitis B Vaccines Revenue by Manufacturers (2015-2020)
3.2.2 Global Hepatitis B Vaccines Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Hepatitis B Vaccines Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hepatitis B Vaccines as of 2019)
3.4 Global Hepatitis B Vaccines Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Hepatitis B Vaccines Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Hepatitis B Vaccines Market
3.7 Key Manufacturers Hepatitis B Vaccines Product Offered
3.8 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Hepatitis B Vaccines Historic Market Review by Type (2015-2020)
4.1.2 Global Hepatitis B Vaccines Sales Market Share by Type (2015-2020)
4.1.3 Global Hepatitis B Vaccines Revenue Market Share by Type (2015-2020)
4.1.4 Hepatitis B Vaccines Price by Type (2015-2020)
4.1 Global Hepatitis B Vaccines Market Estimates and Forecasts by Type (2021-2026)
4.2.2 Global Hepatitis B Vaccines Sales Forecast by Type (2021-2026)
4.2.3 Global Hepatitis B Vaccines Revenue Forecast by Type (2021-2026)
4.2.4 Hepatitis B Vaccines Price Forecast by Type (2021-2026)

5 Global Hepatitis B Vaccines Market Size by Application
5.1 Global Hepatitis B Vaccines Historic Market Review by Application (2015-2020)
5.1.2 Global Hepatitis B Vaccines Sales Market Share by Application (2015-2020)
5.1.3 Global Hepatitis B Vaccines Revenue Market Share by Application (2015-2020)
5.1.4 Hepatitis B Vaccines Price by Application (2015-2020)
5.2 Global Hepatitis B Vaccines Market Estimates and Forecasts by Application (2021-2026)
5.2.2 Global Hepatitis B Vaccines Sales Forecast by Application (2021-2026)
5.2.3 Global Hepatitis B Vaccines Revenue Forecast by Application (2021-2026)
5.2.4 Hepatitis B Vaccines Price Forecast by Application (2021-2026)

6 North America
6.1 North America Hepatitis B Vaccines Breakdown Data by Company
6.2 North America Hepatitis B Vaccines Breakdown Data by Type
6.3 North America Hepatitis B Vaccines Breakdown Data by Application
6.4 North America Hepatitis B Vaccines Breakdown Data by Countries
6.4.1 North America Hepatitis B Vaccines Sales by Countries
6.4.2 North America Hepatitis B Vaccines Revenue by Countries
6.4.3 U.S.
6.4.4 Canada

7 Europe
7.1 Europe Hepatitis B Vaccines Breakdown Data by Company
7.2 Europe Hepatitis B Vaccines Breakdown Data by Type
7.3 Europe Hepatitis B Vaccines Breakdown Data by Application
7.4 Europe Hepatitis B Vaccines Breakdown Data by Countries
7.4.1 Europe Hepatitis B Vaccines Sales by Countries
7.4.2 Europe Hepatitis B Vaccines Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Hepatitis B Vaccines Breakdown Data by Company
8.2 Asia Pacific Hepatitis B Vaccines Breakdown Data by Type
8.3 Asia Pacific Hepatitis B Vaccines Breakdown Data by Application
8.4 Asia Pacific Hepatitis B Vaccines Breakdown Data by Regions
8.4.1 Asia Pacific Hepatitis B Vaccines Sales by Regions
8.4.2 Asia Pacific Hepatitis B Vaccines Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam

9 Latin America
9.1 Latin America Hepatitis B Vaccines Breakdown Data by Company
9.2 Latin America Hepatitis B Vaccines Breakdown Data by Type
9.3 Latin America Hepatitis B Vaccines Breakdown Data by Application
9.4 Latin America Hepatitis B Vaccines Breakdown Data by Countries
9.4.1 Latin America Hepatitis B Vaccines Sales by Countries
9.4.2 Latin America Hepatitis B Vaccines Revenue by Countries
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Hepatitis B Vaccines Breakdown Data by Type
10.2 Middle East and Africa Hepatitis B Vaccines Breakdown Data by Application
10.3 Middle East and Africa Hepatitis B Vaccines Breakdown Data by Countries
10.3.1 Middle East and Africa Hepatitis B Vaccines Sales by Countries
10.3.2 Middle East and Africa Hepatitis B Vaccines Revenue by Countries
10.3.3 Turkey
10.3.4 Saudi Arabia
10.3.5 U.A.E

11 Company Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Corporation Information
11.1.2 GlaxoSmithKline Business Overview and Total Revenue (2019 VS 2018)
11.1.3 GlaxoSmithKline Hepatitis B Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.1.4 GlaxoSmithKline Hepatitis B Vaccines Products and Services
11.1.5 GlaxoSmithKline SWOT Analysis
11.1.6 GlaxoSmithKline Recent Developments
11.2 Merck
11.2.1 Merck Corporation Information
11.2.2 Merck Business Overview and Total Revenue (2019 VS 2018)
11.2.3 Merck Hepatitis B Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.2.4 Merck Hepatitis B Vaccines Products and Services
11.2.5 Merck SWOT Analysis
11.2.6 Merck Recent Developments
11.3 Sanofi Pasteur
11.3.1 Sanofi Pasteur Corporation Information
11.3.2 Sanofi Pasteur Business Overview and Total Revenue (2019 VS 2018)
11.3.3 Sanofi Pasteur Hepatitis B Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.3.4 Sanofi Pasteur Hepatitis B Vaccines Products and Services
11.3.5 Sanofi Pasteur SWOT Analysis
11.3.6 Sanofi Pasteur Recent Developments
11.4 Dynavax Technologies
11.4.1 Dynavax Technologies Corporation Information
11.4.2 Dynavax Technologies Business Overview and Total Revenue (2019 VS 2018)
11.4.3 Dynavax Technologies Hepatitis B Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.4.4 Dynavax Technologies Hepatitis B Vaccines Products and Services
11.4.5 Dynavax Technologies SWOT Analysis
11.4.6 Dynavax Technologies Recent Developments
11.5 Janssen Pharmaceuticals
11.5.1 Janssen Pharmaceuticals Corporation Information
11.5.2 Janssen Pharmaceuticals Business Overview and Total Revenue (2019 VS 2018)
11.5.3 Janssen Pharmaceuticals Hepatitis B Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.5.4 Janssen Pharmaceuticals Hepatitis B Vaccines Products and Services
11.5.5 Janssen Pharmaceuticals SWOT Analysis
11.5.6 Janssen Pharmaceuticals Recent Developments
11.6 LG Life Sciences
11.6.1 LG Life Sciences Corporation Information
11.6.2 LG Life Sciences Business Overview and Total Revenue (2019 VS 2018)
11.6.3 LG Life Sciences Hepatitis B Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.6.4 LG Life Sciences Hepatitis B Vaccines Products and Services
11.6.5 LG Life Sciences SWOT Analysis
11.6.6 LG Life Sciences Recent Developments
11.7 KM Biologics
11.7.1 KM Biologics Corporation Information
11.7.2 KM Biologics Business Overview and Total Revenue (2019 VS 2018)
11.7.3 KM Biologics Hepatitis B Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.7.4 KM Biologics Hepatitis B Vaccines Products and Services
11.7.5 KM Biologics SWOT Analysis
11.7.6 KM Biologics Recent Developments
11.8 Shenzhen Kangtai Biological Products
11.8.1 Shenzhen Kangtai Biological Products Corporation Information
11.8.2 Shenzhen Kangtai Biological Products Business Overview and Total Revenue (2019 VS 2018)
11.8.3 Shenzhen Kangtai Biological Products Hepatitis B Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.8.4 Shenzhen Kangtai Biological Products Hepatitis B Vaccines Products and Services
11.8.5 Shenzhen Kangtai Biological Products SWOT Analysis
11.8.6 Shenzhen Kangtai Biological Products Recent Developments

12 Supply Chain and Sales Channels Analysis
12.1 Supply Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Hepatitis B Vaccines Sales Channels
12.2.2 Hepatitis B Vaccines Distributors
12.3 Hepatitis B Vaccines Customers

13 Estimates and Projections by Regions (2021-2026)
13.1 Global Hepatitis B Vaccines Sales Forecast (2021-2026)
13.1.1 Global Hepatitis B Vaccines Sales Forecast by Regions (2021-2026)
13.1.2 Global Hepatitis B Vaccines Revenue Forecast by Regions (2021-2026)
13.2 North America Market Size Forecast (2021-2026)
13.2.1 North America Hepatitis B Vaccines Sales Forecast (2021-2026)
13.2.2 North America Hepatitis B Vaccines Revenue Forecast (2021-2026)
13.2.3 North America Hepatitis B Vaccines Size Forecast by County (2021-2026)
13.3 Europe Market Size Forecast (2021-2026)
13.3.1 Europe Hepatitis B Vaccines Sales Forecast (2021-2026)
13.3.2 Europe Hepatitis B Vaccines Revenue Forecast (2021-2026)
13.3.3 Europe Hepatitis B Vaccines Size Forecast by County (2021-2026)
13.4 Asia Pacific Market Size Forecast (2021-2026)
13.4.1 Asia Pacific Hepatitis B Vaccines Sales Forecast (2021-2026)
13.4.2 Asia Pacific Hepatitis B Vaccines Revenue Forecast (2021-2026)
13.4.3 Asia Pacific Hepatitis B Vaccines Size Forecast by Region (2021-2026)
13.5 Latin America Market Size Forecast (2021-2026)
13.5.1 Latin America Hepatitis B Vaccines Sales Forecast (2021-2026)
13.5.2 Latin America Hepatitis B Vaccines Revenue Forecast (2021-2026)
13.5.3 Latin America Hepatitis B Vaccines Size Forecast by County (2021-2026)
13.6 Middle East and Africa Market Forecast
13.6.1 Middle East and Africa Hepatitis B Vaccines Sales Forecast (2021-2026)
13.6.2 Middle East and Africa Hepatitis B Vaccines Revenue Forecast (2021-2026)
13.6.3 Middle East and Africa Hepatitis B Vaccines Size Forecast by County (2021-2026)

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Hepatitis B Vaccines Key Market Segments
Table 2. Ranking of Global Top Hepatitis B Vaccines Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Hepatitis B Vaccines Market Size Growth Rate by Type 2021-2026 (K Units) & (Million US$)
Table 4. Major Manufacturers of Mono Vaccines
Table 5. Major Manufacturers of Combination Vaccines
Table 6. Global Hepatitis B Vaccines Market Share by Application 2019-2025 (K Units)
Table 7. Global Hepatitis B Vaccines Market Size by Regions 2015-2020 (K Units) & (Million US$)
Table 8. Global Hepatitis B Vaccines Sales by Regions 2015-2020 (K Units)
Table 9. Global Hepatitis B Vaccines Sales Market Share by Regions 2015-2020
Table 10. Global Hepatitis B Vaccines Revenue by Regions 2015-2020 (Million US$)
Table 11. Global Hepatitis B Vaccines Revenue Market Share by Regions 2015-2020
Table 12. Top Hepatitis B Vaccines Regions (Countries) Ranking by Market Size (US$ Million) in 2019
Table 13. Market Top Trends
Table 14. Hepatitis B Vaccines Key Drivers: Impact Analysis (2021-2026)
Table 15. Hepatitis B Vaccines Key Challenges
Table 16. Main Points Interviewed from Key Hepatitis B Vaccines Players: Views for Future
Table 17. Global Hepatitis B Vaccines Sales by Manufacturers (2015-2020) (K Units)
Table 18. Global Hepatitis B Vaccines Sales Share by Manufacturers (2015-2020)
Table 19. Hepatitis B Vaccines Revenue by Manufacturers (2015-2020) (Million US$)
Table 20. Hepatitis B Vaccines Revenue Share by Manufacturers (2015-2020)
Table 21. Global Hepatitis B Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hepatitis B Vaccines as of 2019)
Table 23. Key Manufacturers Hepatitis B Vaccines Average Selling Price (ASP) (2015-2020) (USD/Unit)
Table 24. Key Manufacturers Hepatitis B Vaccines Plants/Factories Distribution
Table 25. Key Manufacturers Hepatitis B Vaccines Area Served
Table 26. Date of Key Manufacturers Enter into Hepatitis B Vaccines Market
Table 27. Key Manufacturers Hepatitis B Vaccines Product Type
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Mono Vaccines Sales and Revenue (2015-2020) (K Units) & (Million US$)
Table 30. Global Combination Vaccines Sales and Revenue (2015-2020) (K Units) & (Million US$)
Table 31. Global Hepatitis B Vaccines Sales (K Units) by Type (2015-2020)
Table 32. Global Hepatitis B Vaccines Sales Share by Type (2015-2020)
Table 33. Global Hepatitis B Vaccines Revenue (US$ Million) Market Share by Type (2015-2020)
Table 34. Global Hepatitis B Vaccines Price (K Units) by Type (2015-2020)
Table 35. Global Hepatitis B Vaccines Sales (K Units) by Type (2021-2026)
Table 36. Global Hepatitis B Vaccines Sales Share by Type (2021-2026)
Table 37. Global Hepatitis B Vaccines Revenue (US$ Million) Market Share by Type (2021-2026)
Table 38. Global Hepatitis B Vaccines Revenue Share by Type (2021-2026)
Table 39. Global Hepatitis B Vaccines Price (K Units) by Type (2021-2026)
Table 40. Global Hepatitis B Vaccines Sales (K Units) by Application (2015-2020)
Table 41. Global Hepatitis B Vaccines Sales Share by Application (2015-2020)
Table 42. Global Hepatitis B Vaccines Revenue (US$ Million) Market Share by Application (2015-2020)
Table 43. Global Hepatitis B Vaccines Price by Application 2015-2020 (USD/Unit)
Table 44. Global Hepatitis B Vaccines Sales by Application (2015-2020) (K Units)
Table 45. Global Hepatitis B Vaccines Sales Share by Application (2015-2020)
Table 46. Global Hepatitis B Vaccines Revenue (US$ Million) Market Share by Application (2021-2026)
Table 47. Global Hepatitis B Vaccines Revenue Share by Application (2021-2026)
Table 48. Global Hepatitis B Vaccines Price (K Units) by Application (2021-2026)
Table 49. North America Hepatitis B Vaccines Sales by Company (2015-2020) (K Units)
Table 50. North America Hepatitis B Vaccines Sales Market Share by Company (2015-2020)
Table 51. North America Hepatitis B Vaccines Sales by Type (2015-2020) (K Units)
Table 52. North America Hepatitis B Vaccines Sales Market Share by Type (2015-2020)
Table 53. North America Hepatitis B Vaccines Sales by Application (2015-2020) (K Units)
Table 54. North America Hepatitis B Vaccines Sales Market Share by Application (2015-2020)
Table 55. North America Hepatitis B Vaccines Sales by Countries (2015-2020) (K Units)
Table 56. North America Hepatitis B Vaccines Sales Market Share by Countries (2015-2020)
Table 57. North America Hepatitis B Vaccines Revenue by Countries (2015-2020) (Million US$)
Table 58. North America Hepatitis B Vaccines Revenue Market Share by Countries (2015-2020)
Table 59. Europe Hepatitis B Vaccines Sales by Company (2015-2020) (K Units)
Table 60. Europe Hepatitis B Vaccines Sales Market Share by Company (2015-2020)
Table 61. Europe Hepatitis B Vaccines Sales by Type (2015-2020) (K Units)
Table 62. Europe Hepatitis B Vaccines Sales Market Share by Type (2015-2020)
Table 63. Europe Hepatitis B Vaccines Sales by Application (2015-2020) (K Units)
Table 64. Europe Hepatitis B Vaccines Sales Market Share by Application (2015-2020)
Table 65. Europe Hepatitis B Vaccines Sales by Countries (2015-2020) (K Units)
Table 66. Europe Hepatitis B Vaccines Sales Market Share by Countries (2015-2020)
Table 67. Europe Hepatitis B Vaccines Revenue by Countries (2015-2020) (Million US$)
Table 68. Europe Hepatitis B Vaccines Revenue Market Share by Countries (2015-2020)
Table 69. Asia Pacific Hepatitis B Vaccines Sales by Regions (2015-2020) (K Units)
Table 70. Asia Pacific Hepatitis B Vaccines Sales Market Share by Regions (2015-2020)
Table 71. Asia Pacific Hepatitis B Vaccines Sales by Type (2015-2020) (K Units)
Table 72. Asia Pacific Hepatitis B Vaccines Sales Market Share by Type (2015-2020)
Table 73. Asia Pacific Hepatitis B Vaccines Sales by Application (2015-2020) (K Units)
Table 74. Asia Pacific Hepatitis B Vaccines Sales Market Share by Application (2015-2020)
Table 75. Asia Pacific Hepatitis B Vaccines Sales by Countries (2015-2020) (K Units)
Table 76. Asia Pacific Hepatitis B Vaccines Sales Market Share by Regions (2015-2020)
Table 77. Asia Pacific Hepatitis B Vaccines Revenue by Regions (2015-2020) (Million US$)
Table 78. Asia Pacific Hepatitis B Vaccines Revenue Market Share by Regions (2015-2020)
Table 79. Latin America Hepatitis B Vaccines Sales by Company (2015-2020) (K Units)
Table 80. Latin America Hepatitis B Vaccines Sales Market Share by Company (2015-2020)
Table 81. Latin America Hepatitis B Vaccines Sales by Type (2015-2020) (K Units)
Table 82. Latin America Hepatitis B Vaccines Sales Market Share by Type (2015-2020)
Table 83. Latin America Hepatitis B Vaccines Sales by Application (2015-2020) (K Units)
Table 84. Latin America Hepatitis B Vaccines Sales Market Share by Application (2015-2020)
Table 85. Latin America Hepatitis B Vaccines Sales by Countries (2015-2020) (K Units)
Table 86. Latin America Hepatitis B Vaccines Sales Market Share by Countries (2015-2020)
Table 87. Latin America Hepatitis B Vaccines Revenue by Countries (2015-2020) (Million US$)
Table 88. Latin America Hepatitis B Vaccines Revenue Market Share by Countries (2015-2020)
Table 89. Middle East and Africa Hepatitis B Vaccines Sales by Type (2015-2020) (K Units)
Table 90. Middle East and Africa Hepatitis B Vaccines Sales Market Share by Type (2015-2020)
Table 91. Middle East and Africa Hepatitis B Vaccines Sales by Application (2015-2020) (K Units)
Table 92. Middle East and Africa Hepatitis B Vaccines Sales Market Share by Application (2015-2020)
Table 93. Middle East and Africa Hepatitis B Vaccines Sales by Countries (2015-2020) (K Units)
Table 94. Middle East and Africa Hepatitis B Vaccines Sales Market Share by Countries (2015-2020)
Table 95. Middle East and Africa Hepatitis B Vaccines Revenue by Countries (2015-2020) (Million US$)
Table 96. Middle East and Africa Hepatitis B Vaccines Revenue Market Share by Countries (2015-2020)
Table 97. GlaxoSmithKline Company Details
Table 98. GlaxoSmithKline Description and Business Overview
Table 99. GlaxoSmithKline Hepatitis B Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 100. GlaxoSmithKline Hepatitis B Vaccines Sales Growth Rate (2015-2020)
Table 101. GlaxoSmithKline Hepatitis B Vaccines Sales Market Share in Global Market
Table 102. GlaxoSmithKline Recent Development
Table 103. Merck Company Details
Table 104. Merck Description and Business Overview
Table 105. Merck Hepatitis B Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 106. Merck Hepatitis B Vaccines Sales Growth Rate (2015-2020)
Table 107. Merck Hepatitis B Vaccines Sales Market Share in Global Market
Table 108. Merck Recent Development
Table 109. Sanofi Pasteur Company Details
Table 110. Sanofi Pasteur Description and Business Overview
Table 111. Sanofi Pasteur Hepatitis B Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Sanofi Pasteur Hepatitis B Vaccines Sales Growth Rate (2015-2020)
Table 113. Sanofi Pasteur Hepatitis B Vaccines Sales Market Share in Global Market
Table 114. Sanofi Pasteur Recent Development
Table 115. Dynavax Technologies Company Details
Table 116. Dynavax Technologies Description and Business Overview
Table 117. Dynavax Technologies Hepatitis B Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 118. Dynavax Technologies Hepatitis B Vaccines Sales Growth Rate (2015-2020)
Table 119. Dynavax Technologies Hepatitis B Vaccines Sales Market Share in Global Market
Table 120. Dynavax Technologies Recent Development
Table 121. Janssen Pharmaceuticals Company Details
Table 122. Janssen Pharmaceuticals Description and Business Overview
Table 123. Janssen Pharmaceuticals Hepatitis B Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 124. Janssen Pharmaceuticals Hepatitis B Vaccines Sales Growth Rate (2015-2020)
Table 125. Janssen Pharmaceuticals Hepatitis B Vaccines Sales Market Share in Global Market
Table 126. Janssen Pharmaceuticals Recent Development
Table 127. LG Life Sciences Company Details
Table 128. LG Life Sciences Description and Business Overview
Table 129. LG Life Sciences Hepatitis B Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 130. LG Life Sciences Hepatitis B Vaccines Sales Growth Rate (2015-2020)
Table 131. LG Life Sciences Hepatitis B Vaccines Sales Market Share in Global Market
Table 132. LG Life Sciences Recent Development
Table 133. KM Biologics Company Details
Table 134. KM Biologics Description and Business Overview
Table 135. KM Biologics Hepatitis B Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 136. KM Biologics Hepatitis B Vaccines Sales Growth Rate (2015-2020)
Table 137. KM Biologics Hepatitis B Vaccines Sales Market Share in Global Market
Table 138. KM Biologics Recent Development
Table 139. Shenzhen Kangtai Biological Products Company Details
Table 140. Shenzhen Kangtai Biological Products Description and Business Overview
Table 141. Shenzhen Kangtai Biological Products Hepatitis B Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 142. Shenzhen Kangtai Biological Products Hepatitis B Vaccines Sales Growth Rate (2015-2020)
Table 143. Shenzhen Kangtai Biological Products Hepatitis B Vaccines Sales Market Share in Global Market
Table 144. Shenzhen Kangtai Biological Products Recent Development
Table 145. Hepatitis B Vaccines Distributors List
Table 146. Hepatitis B Vaccines Customers List
Table 147. Global Hepatitis B Vaccines Sales Forecast 2021-2026 (K Units) & (Million US$)
Table 148. Global Hepatitis B Vaccines Sales Forecast by Type 2021-2026 (K Units)
Table 149. Global Hepatitis B Vaccines Sales Forecast by Application 2021-2026 (K Units)
Table 150. Global Hepatitis B Vaccines Sales Forecast by Regions 2021-2026 (K Units)
Table 151. Global Hepatitis B Vaccines Revenue Forecast by Regions 2021-2026 (Million US$)
Table 152. North America Hepatitis B Vaccines Sales Forecast by Countries 2021-2026 (K Units)
Table 153. North America Hepatitis B Vaccines Revenue Forecast by Countries 2021-2026
Table 154. Europe Hepatitis B Vaccines Sales Forecast by Countries 2021-2026 (K Units)
Table 155. Europe Hepatitis B Vaccines Revenue Market Share Forecast by Countries 2021-2026
Table 156. Asia Pacific Hepatitis B Vaccines Sales Forecast by Regions 2021-2026 (K Units)
Table 157. Asia Pacific Hepatitis B Vaccines Revenue Forecast by Regions 2021-2026 (Million US$)
Table 158. Latin America Hepatitis B Vaccines Sales Forecast by Countries 2021-2026 (K Units)
Table 159. Latin America Hepatitis B Vaccines Revenue Forecast by Countries 2021-2026 (Million US$)
Table 160. Middle East and Africa Hepatitis B Vaccines Sales Forecast by Regions 2021-2026 (K Units)
Table 161. Middle East and Africa Hepatitis B Vaccines Revenue Forecast by Regions 2021-2026 (Million US$)
Table 162. Research Programs/Design for This Report
Table 163. Key Data Information from Secondary Sources
Table 164. Key Data Information from Primary Sources
List of Figures
Figure 1. Hepatitis B Vaccines Product Picture
Figure 2. Global Hepatitis B Vaccines Sales Market Shar by Type 2015-2026
Figure 3. Mono Vaccines Figures
Figure 4. Combination Vaccines Figures
Figure 5. Global Hepatitis B Vaccines Sales Market Share by Application in 2019 & 2026
Figure 6. adr Use Case
Figure 7. adw Use Case
Figure 8. ayr Use Case
Figure 9. ayw Use Case
Figure 10. Hepatitis B Vaccines Report Years Considered
Figure 11. Global Hepatitis B Vaccines Market Size 2015-2026 (Million US$)
Figure 12. Global Hepatitis B Vaccines Sales 2015-2020 (K Units)
Figure 13. Global Hepatitis B Vaccines Market Size Market Share by Regions 2015-2020
Figure 14. Global Hepatitis B Vaccines Sales Market Share by Regions in 2019
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Hepatitis B Vaccines Sales Share by Manufacturers in 2019
Figure 17. The 5 and 10 Largest Manufacturers in the World: Market Share by Hepatitis B Vaccines Sales in 2019
Figure 18. Hepatitis B Vaccines Value Share by Manufacturers in 2019
Figure 19. Hepatitis B Vaccines Revenue Share by Manufacturers In 2019
Figure 20. Hepatitis B Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Hepatitis B Vaccines Revenue Share by Type (2015-2020)
Figure 22. Global Hepatitis B Vaccines Revenue Growth Rate by Type in 2015 & 2019
Figure 23. Global Hepatitis B Vaccines Market Share by Price Range (2015-2020)
Figure 24. Global Hepatitis B Vaccines Revenue Share by Application (2015-2020)
Figure 25. Global Hepatitis B Vaccines Revenue Growth Rate by Application in 2015 & 2019
Figure 26. North America Hepatitis B Vaccines Revenue Growth Rate 2015-2020 (Million US$)
Figure 27. U.S. Hepatitis B Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 28. Canada Hepatitis B Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 29. Europe Hepatitis B Vaccines Revenue Growth Rate 2015-2020 (Million US$)
Figure 30. Germany Hepatitis B Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 31. France Hepatitis B Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 32. U.K. Hepatitis B Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 33. Italy Hepatitis B Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 34. Russia Hepatitis B Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 35. Asia Pacific Hepatitis B Vaccines Revenue Growth Rate 2015-2020 (Million US$)
Figure 36. China Hepatitis B Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 37. Japan Hepatitis B Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 38. South Korea Hepatitis B Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 39. India Hepatitis B Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 40. Australia Hepatitis B Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 41. Taiwan Hepatitis B Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 42. Indonesia Hepatitis B Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 43. Thailand Hepatitis B Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 44. Malaysia Hepatitis B Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 45. Philippines Hepatitis B Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 46. Vietnam Hepatitis B Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 47. Latin America Hepatitis B Vaccines Revenue Growth Rate 2015-2020 (Million US$)
Figure 48. Mexico Hepatitis B Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 49. Brazil Hepatitis B Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 50. Argentina Hepatitis B Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 51. Middle East and Africa Hepatitis B Vaccines Revenue Growth Rate 2015-2020 (Million US$)
Figure 52. Turkey Hepatitis B Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 53. Saudi Arabia Hepatitis B Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 54. U.A.E Hepatitis B Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 55. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Sanofi Pasteur Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Dynavax Technologies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Janssen Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. LG Life Sciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. KM Biologics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Shenzhen Kangtai Biological Products Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Hepatitis B Vaccines Value Chain
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
Figure 66. North America Hepatitis B Vaccines Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 67. North America Hepatitis B Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 68. Europe Hepatitis B Vaccines Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 69. Europe Hepatitis B Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 70. Asia Pacific Hepatitis B Vaccines Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 71. Asia Pacific Hepatitis B Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 72. Latin America Hepatitis B Vaccines Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 73. Latin America Hepatitis B Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 74. Middle East and Africa Hepatitis B Vaccines Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 75. Middle East and Africa Hepatitis B Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed


【掲載企業】

GlaxoSmithKline、Merck、Sanofi Pasteur、Dynavax Technologies、Janssen Pharmaceuticals、LG Life Sciences、KM Biologics、Shenzhen Kangtai Biological Products

★調査レポート[世界のB型肝炎ワクチン市場:成長動向・競争分析2020-2026] (コード:QYR20AP00992)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のB型肝炎ワクチン市場:成長動向・競争分析2020-2026]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆